NovaDel Reports Financial Results for Second Quarter 2007Business Wire (press release), CA - 14 hours agoIn June 2007, NovaDel announced its clinical development and financial resource strategy for advancing its near-term drug candidates, zolpidem oral spray …
Read full story
NovaDel Reports Financial Results for Second Quarter 2007Genetic Engineering News (press release), NY - 14 hours agoIn June 2007, NovaDel announced its clinical development and financial resource strategy for advancing its near-term drug candidates, zolpidem oral spray …
Read full story
Takeda seeing more patients name-check Rozerem; will sales followMedical Marketing and Media, NY - Aug 7, 2007The advertising tweaks follow the introduction of generic Ambien in May, which will drive down the cost of zolpidem. Other challenges include internal …
Read full story
Express PharmaFlamingo bags CRAMS order from TevaExpress Pharma, India - Aug 8, 2007Flamingo Pharma has received the initial order to manufacture 10 million 10 mg tablets and would be shipping the first batch of Zolpidem by October 2007. …
Read full story
Electric current boosts injured brainScience Daily (press release) - 6 hours agofull story Insomnia Drug Can Improve Brain Function In Certain Patients (March 14, 2007) — A new study reported that zolpidem, a drug normally used to …
Read full story
Alcohol Use and AnxietyAm J Psychiatry (subscription) - Aug 1, 2007… either a benzodiazepine or a nonbenzodiazepine GABA-BZ receptor agonist hypnotic, such as zolpidem or eszopiclone, to treat the patient’s insomnia. …
Read full story
Flamingo Pharma to mfg Zolpidem for TevaMoneycontrol.com, India - Jul 19, 2007Zolpidem is the 6 th product manufactured by the company for the Teva Group. Flamingo Pharma has received the initial order to manufacture 10 million 10mg …
Read full story
A difficult quarter for Sanofi ends with profit declines, shares fallPharma Times (subscription), UK - 1 hour agoThe most striking feature was the decline in income suffered by Stilnox/Ambien (zolpidem) sleeping pill franchise as the quarter saw a whole host of copycat …
Read full story
Sepracor Inc. Announces Second Quarter 2007 Results and …Genetic Engineering News (press release), NY - Jul 27, 2007This growth occurred despite introduction of the generic competitor, zolpidem tartrate, which occurred during the quarter. XOPENEX(R) brand levalbuterol HCl …
Read full story
Contract manufacturing news in briefIn-PharmaTechnologist.com, UK - 8 hours agoMeanwhile, Indian firm Flamingo Pharmaceuticals has inked a deal with Teva Group to manufacture zolpidem tartrate tablets, an insomnia treatment, …
Read full story